These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 21745282

  • 1. The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.
    Wang CW, Lin HY, Shin SJ, Yu ML, Lin ZY, Dai CY, Huang JF, Chen SC, Li SS, Chuang WL.
    Liver Int; 2011 Oct; 31(9):1326-31. PubMed ID: 21745282
    [Abstract] [Full Text] [Related]

  • 2. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
    Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP.
    Hepatology; 2010 Apr; 51(4):1209-17. PubMed ID: 20373368
    [Abstract] [Full Text] [Related]

  • 3. Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.
    Franko A, Merkel D, Kovarova M, Hoene M, Jaghutriz BA, Heni M, Königsrainer A, Papan C, Lehr S, Häring HU, Peter A.
    Nutrients; 2018 Sep 17; 10(9):. PubMed ID: 30227635
    [Abstract] [Full Text] [Related]

  • 4. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
    Rametta R, Ruscica M, Dongiovanni P, Macchi C, Fracanzani AL, Steffani L, Fargion S, Magni P, Valenti L.
    Eur J Clin Invest; 2014 Jul 17; 44(7):627-33. PubMed ID: 24828988
    [Abstract] [Full Text] [Related]

  • 5. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
    Park JH, Cho B, Kwon H, Prilutsky D, Yun JM, Choi HC, Hwang KB, Lee IH, Kim JI, Kong SW.
    Liver Int; 2015 Dec 17; 35(12):2537-46. PubMed ID: 26148225
    [Abstract] [Full Text] [Related]

  • 6. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
    Chen LZ, Xin YN, Geng N, Jiang M, Zhang DD, Xuan SY.
    World J Gastroenterol; 2015 Jan 21; 21(3):794-802. PubMed ID: 25624712
    [Abstract] [Full Text] [Related]

  • 7. Association of the I148M/PNPLA3 (rs738409) polymorphism with premature coronary artery disease, fatty liver, and insulin resistance in type 2 diabetic patients and healthy controls. The GEA study.
    Posadas-Sánchez R, López-Uribe ÁR, Posadas-Romero C, Pérez-Hernández N, Rodríguez-Pérez JM, Ocampo-Arcos WA, Fragoso JM, Cardoso-Saldaña G, Vargas-Alarcón G.
    Immunobiology; 2017 Oct 21; 222(10):960-966. PubMed ID: 27615511
    [Abstract] [Full Text] [Related]

  • 8. Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity.
    Hyysalo J, Gopalacharyulu P, Bian H, Hyötyläinen T, Leivonen M, Jaser N, Juuti A, Honka MJ, Nuutila P, Olkkonen VM, Oresic M, Yki-Järvinen H.
    Diabetes; 2014 Jan 21; 63(1):312-22. PubMed ID: 24009255
    [Abstract] [Full Text] [Related]

  • 9. The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls.
    Valenti L, Rametta R, Ruscica M, Dongiovanni P, Steffani L, Motta BM, Canavesi E, Fracanzani AL, Mozzi E, Roviaro G, Magni P, Fargion S.
    BMC Gastroenterol; 2012 Aug 16; 12():111. PubMed ID: 22898488
    [Abstract] [Full Text] [Related]

  • 10. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
    Arslanow A, Stokes CS, Weber SN, Grünhage F, Lammert F, Krawczyk M.
    Liver Int; 2016 Mar 16; 36(3):418-26. PubMed ID: 26264356
    [Abstract] [Full Text] [Related]

  • 11. PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes.
    Karamfilova V, Gateva A, Assyov Y, Alexiev A, Savov A, Yaneva N, Ivanova I, Ivanova-Boyanova R, Ivanova R, Vlahova Z, Mateva L, Kamenov Z.
    J Gastrointestin Liver Dis; 2019 Dec 09; 28(4):433-438. PubMed ID: 31826069
    [Abstract] [Full Text] [Related]

  • 12. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S.
    World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190
    [Abstract] [Full Text] [Related]

  • 13. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Donati B, Motta BM, Pingitore P, Meroni M, Pietrelli A, Alisi A, Petta S, Xing C, Dongiovanni P, del Menico B, Rametta R, Mancina RM, Badiali S, Fracanzani AL, Craxì A, Fargion S, Nobili V, Romeo S, Valenti L.
    Hepatology; 2016 Mar 14; 63(3):787-98. PubMed ID: 26605757
    [Abstract] [Full Text] [Related]

  • 14. The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population.
    Martínez LA, Larrieta E, Kershenobich D, Torre A.
    Ann Hepatol; 2016 Mar 14; 16(6):909-915. PubMed ID: 29055919
    [Abstract] [Full Text] [Related]

  • 15. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals.
    Lin YC, Chang PF, Chang MH, Ni YH.
    Am J Clin Nutr; 2014 Apr 14; 99(4):869-74. PubMed ID: 24477042
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease.
    Sookoian S, Pirola CJ.
    Hepatology; 2011 Jun 14; 53(6):1883-94. PubMed ID: 21381068
    [Abstract] [Full Text] [Related]

  • 17. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
    Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH.
    J Pediatr; 2011 May 14; 158(5):740-4. PubMed ID: 21168155
    [Abstract] [Full Text] [Related]

  • 18. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.
    Lee SS, Byoun YS, Jeong SH, Woo BH, Jang ES, Kim JW, Kim HY.
    Dig Dis Sci; 2014 Dec 14; 59(12):2967-74. PubMed ID: 25069572
    [Abstract] [Full Text] [Related]

  • 19. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans.
    Kovarova M, Königsrainer I, Königsrainer A, Machicao F, Häring HU, Schleicher E, Peter A.
    J Clin Endocrinol Metab; 2015 Dec 14; 100(12):E1568-74. PubMed ID: 26439088
    [Abstract] [Full Text] [Related]

  • 20. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
    Krawczyk M, Jiménez-Agüero R, Alustiza JM, Emparanza JI, Perugorria MJ, Bujanda L, Lammert F, Banales JM.
    Surg Obes Relat Dis; 2016 Dec 14; 12(10):1838-1846. PubMed ID: 27576208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.